2017-06-19

[#DIV28SUPER] Invitation to participate in Prescribing survey

Posted at the request of Matt Turner mturner@asppb.org: via Emily Laumeier

 

 

Association of State and Provincial Psychology Boards

 


Supporting member jurisdictions in fulfilling
their responsibility of public protection.

 

June 15, 2017

 

Dear Colleagues,

As you are likely aware, the Association of State and Provincial Psychology Boards (ASPPB) is conducting a survey of the practice of prescribing psychologists (Job Task Analysis (JTA)).  It is critical that we receive input from as many individuals that have the knowledge, skills, and experience to inform us on the current knowledge-base required for this type of practice.  Input received will determine what is measured on the Psychopharmacology Examination for Psychologist (PEP). 

If you have not already done so, please take the time to complete the survey below. 

 

https://survey.co1.qualtrics.com/jfe/form/SV_9LbSKCzNK8ZzXwN

 

Based on the experience of those who have already completed the survey, it will take only about 30 minutes or less of your time and you do not have to complete it all in one sitting.  The program remembers your progress and you can return to the spot you stopped when you have time to complete the survey.

Again, your input is very important so we hope you will consider completing this survey.  All respondents will be placed in a drawing for one of three $100 gift cards in appreciation of your participation.  The survey closes on June 26.    

 

Please pass on this link to any colleague that is trained as a prescribing psychologist even though they may not be currently prescribing. 

 

Thank you in advance,

 

Joseph E. Comaty, PhD. M.P.

Chair, PEP-Job Task Analysis Task Force (PEP-JTATF)

drscomatyadvokat@gmail.com

 

Matt Turner, PhD.

ASPPB Director of Examinations Services

mturner@asppb.org

 

 

 

 

 

 

 

 

2017-06-16

[#DIV28SUPER] Editorial Fellowship Available for Experimental and Clinical Psychopharmacology

Dear Colleagues-
Please feel free to distribute this call to any groups or individuals who might be interested.
Thanks,
Bill Stoops
Incoming Editor, Experimental and Clinical Psychopharmacology

Experimental and Clinical Psychopharmacology will be adding an Editorial Fellow position, beginning January 1, 2018. The position is open to qualified candidates who hold the rank of Assistant Professor (or equivalent) and will last one year. During this time, the selected Fellow will work closely with the journal's Editor, Dr. William W. Stoops, to develop editorial and publishing proficiency, enrich scientific knowledge and bolster written communication skills. It is anticipated that the Fellow will manage approximately one manuscript per month. This process will include identifying reviewers, making an editorial decision based on review and shepherding the manuscript through to publication if accepted, all with guidance from Dr. Stoops. The successful candidate will also be expected to participate in monthly meetings with Dr. Stoops to ensure goals are met and problems are identified and addressed. The majority of these meetings will be phone conferences, although in-person meetings at scientific conferences are also possible. Upon successful completion of the fellowship, the Editorial Fellow will become a member of the journal's editorial board. All applications should include the following: 1) an interest statement, 2) a curriculum vitae and 3) three recommendation letters. Application materials are due to Dr. Stoops (william.stoops@uky.edu) on September 1, 2017 at 5 PM Eastern time and should be submitted as a single pdf file. Applications will be reviewed by members of the Experimental and Clinical Psychopharmacology editorial board for strength of the interest statement, research and publishing experience, manuscript review experience and enthusiasm of the recommendation letters. The top candidate will be notified of her/his selection by December 1, 2017. Address any questions to Dr. Stoops at william.stoops@uky.edu.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2017-06-12

[#DIV28SUPER] New Fellows Nominations

Dear all,

Division 28 is seeking nominations for new Fellows. If you would like to nominate yourself or a colleague as a Fellow, please do so.

As described by APA, "Fellow status is an honor bestowed upon APA members who have shown evidence of unusual and outstanding contributions or performance in the field of psychology. Fellow status requires that a person's work has had a national impact on the field of psychology beyond a local, state or regional level. A high level of competence or steady and continuing contributions are not sufficient to warrant fellow status. National impact must be demonstrated."

In Division 28 a successful nominee will typically be 10-15 years post-doctorate, have a minimum of 30 publications and a track record of external funding, and can document national impact of her or his research.

If you would like to nominate a colleague for consideration for Fellow status,  please send her or his CV and contact information to the address below. You may also nominate somebody who is already an APA Fellow (with relevance to our Division), but who is not yet a Fellow of Division 28.  Self-nominations are also welcomed.

Thanks,
Matt
Contact Information for Fellow Nominations:
Matthew W. Johnson, Ph.D.
Division 28 Fellows Chair
Email: mwj@jhu.edu

--
Matthew W. Johnson, Ph.D.
Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD  21224-6823
Tel: 410-550-0056
Fax: 410-550-0030
Email: mwj@jhu.edu

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

2017-06-09

[#DIV28SUPER] You're Invited! APA's Annual Education Advocacy Breakfast Meeting at Convention- focus on opioids

Greetings Division 28 members,

The APA Education Directorate is hosting an advocacy breakfast at the 2017 Annual Convention that will focus on the opioid epidemic. All are welcome to attend, please click the link to register. 

Warm regards,
Kelly  

 

 

 

Dana Leinbach

Legislative Assistant

Office of Education Government Relations

Education Directorate
American Psychological Association
750 First Street NE, Washington, DC 20002-4242
Tel: (202) 336-5982

Email: dleinbach@apa.org | www.apa.org

cid:image001.png@01D0F9D6.C613AC40 cid:image002.png@01D0F9D6.C613AC40 cid:image003.jpg@01D0F9D6.C613AC40 cid:image004.jpg@01D0F9D6.C613AC40

cid:image002.png@01D2654D.477D0AF0

 

 


2017-06-07

[#DIV28SUPER] 5th ANNUAL VERMONT CENTER ON BEHAVIOR AND HEALTH CONFERENCE


5th Annual Conference: Tobacco Regulatory Science

October 5-6, 2017

Burlington Hilton Hotel

Burlington, Vermont

 

The theme of this year’s conference is Tobacco Regulatory Science, with particular focus on vulnerable populations. Regulating the nicotine content of cigarettes and other products is an important responsibility of the FDA that has tremendous potential to reduce smoking prevalence and improve the U.S. public health. Scholars from leading U.S. universities and medical centers will share their research and knowledge throughout the 2-day program. 

 

This year’s keynote speaker is Mitch Zeller, J.D., Director, Center for Tobacco Products, U.S. Food and Drug Administration. Director Zeller leads the FDA’s efforts to reduce the disease and death from tobacco use and bring previously unavailable information about its dangers to light. He is dedicated to carrying out CTP's charge to reduce the harm from all tobacco products across the entire population – with a focus on how and why people start, stop, or start again after stopping.

 

We are also announcing the call for poster abstracts in the focus area of tobacco regulatory science. Posters will be reviewed and considered on a rolling basis; abstracts will be evaluated on the basis of scientific merit. Please send submissions (including title, authors, affiliations and a 250-word abstract) to Diann Gaalema, Ph.D., at Diann.Gaalema@med.uvm.edu before July 31.

 

For conference program, registration and hotel links, please visit our website and/or conference page.

 

For general information, contact Marissa Wells at mwells@uvm.edu.


--

Stephen T. Higgins, Ph.D.
Director, Vermont Center on Behavior and Health
Virginia H. Donaldson Professor of Translational Science
Departments of Psychiatry and Psychology
Vice Chair, Department of Psychiatry
University of Vermont
1 South Prospect Street
Burlington, VT  05401-1419

VCBH Administrator: Marissa Wells
mwells2@uvm.edu
802-656-0079

2017-05-30

[#DIV28SUPER] Contributors needed

Sent on behalf of Dr. Suzette Evans:

Contributors needed for a new American Psychological Association publication: APA Handbook of Psychopharmacology

The APA Handbook of Psychopharmacology (edited by Suzette M. Evans, PhD and Kenneth M. Carpenter, PhD) will provide a working knowledge of basic pharmacology and psychopharmacology in a language suitable for the targeted readership, and summarize the current and emerging research and clinical evidence related to the pharmacologic treatment of mental health disorders. Although psychopharmacology is constantly changing, particularly as new medications emerge, this handbook will provide a solid foundation of the field specifically geared towards psychologists. Our target audience primarily includes established psychology researchers and practitioners, but the Handbook will also be of value to allied social and behavioral scientists, as well as professionals in complementary fields such as clinical social work and mental health counseling. Moreover, psychology graduate students will find the chapters in the Handbook extremely valuable for gaining a sound familiarity with major specialties across the field.

While we have identified contributors for most of the chapters, we are still looking for colleagues willing to write some highly relevant chapters (each is highlighted in BLUE below). This would be an excellent opportunity for an expert in one of the areas below to co-author a chapter with a junior colleague (e.g., graduate student, postdoctoral fellow, junior faculty member). If you are interested in contributing one of these chapters, or have suggestions of other potential contributors with expertise in any of these areas, please contact Suzette Evans directly at se18@cumc.columbia.edu

Basic Information on Psychotropic Drugs, Receptor Systems and the Brain

a.     Structure/Function of the Nervous System

b.     Overview of Relevant Neurotransmitters

1)    Catecholamines (primarily Dopamine)

2)    Serotonin

3)    Acetylcholine

4)    Gamma-aminobutyric Acid (GABA) and Glutamate

5)    Morphine-like substances (Endorphins, Enkephalins)

c.     Drugs Have Multiple Actions

d.     Exogenous Drugs can Mimic Endogenous Compounds

Basic Pharmacology

a.     Drug terminology (Dose, Safety, Potency, Efficacy)

b.     Routes of Administration

c.     Distribution and Pharmacokinetics

d.     Pharmacodynamics

e.     Individual Factors (e.g., Sex, Age, Genetics)

f.      Drug Interactions

The Role of Animal Laboratory Research in Psychopharmacology*

The Role of Human Laboratory Research in Psychopharmacology*

Role of Pharma Industry and their Place in the Treatment of Mental Health Disorders*

 (*These chapters would need to extend to all areas of psychopharmacology, not just substance abuse)


               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
phone: (859) 257-5383
facsimile: (859) 257-7684


Associate Professor
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology

Director
Regulatory Knowledge and Support Core
Component Lead
Research Methods
University of Kentucky Center for Clinical and Translational Science

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

2017-05-19

[#DIV28SUPER] UVM NIH POSTDOCTORAL RESEARCH FELLOWSHIP POSITION

NIH Postdoctoral Research Fellowship Opportunity

 

The University of Vermont’s Center on Behavior and Health (VCBH) announces NIH postdoctoral research fellowship opportunities in our internationally recognized center of excellence for the study of substance abuse. 

Eligibility: Applicants must have completed their training in psychology, behavior analysis, cognitive neuroscience, or a related discipline. Trainees are selected on the basis of scholastic record and commitment to a career in neuroimaging and substance abuse research. Individuals must be highly motivated, possess initiative and a desire to learn and expand their interests and expertise.

 

 Appointment:  2-3 yrs.

 

 Benefits: Stipend, medical insurance coverage, and travel funds supported by NIH Institutional Training Awards.

 

To apply: Send application form (downloaded from VCBH website), a cover letter, curriculum vitae, statement of research interests, and 3 letters of reference to:  Dr. Stephen Higgins c/o Ms. Marissa Wells (mwells2@uvm.edu). General inquiries can be directed to Dr. Hugh Garavan (hgaravan@uvm.edu) and cc’ Ms. Marissa Wells.

 

About us: The VCBH was established in 2013, sponsored in part by a Centers of Biomedical Research Excellence (COBRE) Award from the National Institute on General Medical Sciences and a Centers of Tobacco Regulatory Science (TCORS) Award from the National Institute on Drug Abuse. The VCBH resides within the College of Medicine at the University of Vermont, with the director and administrative offices being located within the Department of Psychiatry, and participating investigators, collaborators, and advisors across 15 academic departments in the College of Medicine and 7 colleges within the University of Vermont and 5 other universities. The VCBH is further strengthened by interdisciplinary collaborations with key community healthcare leaders and distinguished scientific advisory panels. The focus of the VCBH is on investigating relationships between personal behaviors and risk for chronic disease and premature death, with a specific focus on understanding mechanisms underpinning risk, and developing effective interventions and policies to promote healthy behavior.

 

 For more information:  Contact Ms. Marissa Wells at mwells2@uvm.edu or see our website.

 

 

 Burlington, Vermont is located in the beautiful Lake Champlain region, surrounded by the Green and Adirondack Mountains. It is a great place for families, boasting excellent schools and year-round recreational opportunities. It is home to the University of Vermont and many other colleges that provide an academically stimulating and culturally rich environment. Montreal and Boston are within easy driving distances.


--

Stephen T. Higgins, Ph.D.
Director, Vermont Center on Behavior and Health
Virginia H. Donaldson Professor of Translational Science
Departments of Psychiatry and Psychology
Vice Chair, Department of Psychiatry
University of Vermont
1 South Prospect Street
Burlington, VT  05401-1419

VCBH Administrator: Marissa Wells
mwells2@uvm.edu
802-656-0079